Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201204060 Principal Investigator: Romee, Rizwan
Title: Randomized Phase III Trial of haploidentical HCT with or without an add back strategy of HSV-Tk donor lymphocytes in patients with high risk acute leukemia
Phase: III Disease Site: Myeloid and Monocytic Leukemia
Participating Site(s):
 
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to determine if there is an increased in survival rate in patients who undergo a HCT transplantation followed by an infusion of genetically modified HSV-TK donor lymphocytes, compared to patients who have the standard HCT transplantation? with the standard infusion of hematopoietic stem cell and a fixed dose of T cells.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)